David Jacobs, PharmD, PhD, hired as Assistant Professor of Pharmacy Practice

Jacobs

By Kara Sweet

Published July 2, 2018

BUFFALO, N.Y. – The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is pleased to announce the hiring of David M. Jacobs, PharmD ‘11, PhD ’18, as assistant professor, pharmacy practice.

“With his training as a PharmD and PhD in epidemiology, Dr. Jacobs is well positioned to assume an important role in the school as a clinician-scientist.”
James M. O'Donnell, PhD, Dean and Professor
School of Pharmacy and Pharmaceutical Sciences

“Dr. Jacobs will help advance our department’s clinical research endeavors,” says William Prescott, interim chair and clinical associate professor, pharmacy practice. “His research, individually and through strategic collaboration with his colleagues, focuses on pharmaceutical health services and outcomes research, pharmacoepidemiology, comparative effectiveness research and implementation science.”

Jacobs completed a PGY-1 Pharmacy Practice Residency at the University of Toledo Medical Center, a PGY-2 Infectious Diseases Residency at the University of Houston College of Pharmacy, and a Clinical Research Fellowship in Pharmacoepidemiology at the UB School of Pharmacy and Pharmaceutical Sciences.

Since 2014, Jacobs has been working part-time as a clinical assistant professor in the Department of Pharmacy Practice, while he pursued his PhD in epidemiology from the UB School of Public Health and Health Professions.  He recently completed his PhD in epidemiology with his dissertation entitled “Relationships between bacteria, exacerbations, and hospitalizations in chronic obstructive pulmonary disease.”

“With his training as a PharmD and PhD in epidemiology, Dr. Jacobs is well positioned to assume an important role in the school as a clinician-scientist,” says James O’Donnell, PhD, dean. “We are fortunate to have him join the pharmacy practice department as a tenure-track assistant professor.”

Jacobs is a member of multiple professional organizations and has over 20 peer-reviewed publications.  He is also co-investigator on a RTOP 2017 SIP2 award from the Centers for Medicare and Medicaid Services entitled “Optimizing Pain Management and Opioid Safety: A Community Pharmacy Intervention to Prevent Opioid Adverse Drug Events.”

He was the recipient of a highly-competitive 2017 National Institutes of Health Clinical Loan Repayment Program Award from the National Heart, Lung and Blood Institute for his research proposal ‘Clinical epidemiology in chronic obstructive pulmonary disease’. More recently, he received the Buffalo Translational Consortium Mentored Career Development Award for his project entitled, “A pilot study to evaluate objective assessment tools to improve medication management in chronic obstructive pulmonary disease.”

For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and ranked as one of the top 25 schools of pharmacy and pharmaceutical sciences in the United States.